0000014272-22-000170.txt : 20220915 0000014272-22-000170.hdr.sgml : 20220915 20220915192945 ACCESSION NUMBER: 0000014272-22-000170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220913 FILED AS OF DATE: 20220915 DATE AS OF CHANGE: 20220915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elkins David V CENTRAL INDEX KEY: 0001451604 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 221246768 MAIL ADDRESS: STREET 1: C/O BECTON, DICKINSON AND COMPANY STREET 2: 1 BECTON DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 wf-form4_166328457044815.xml FORM 4 X0306 4 2022-09-13 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001451604 Elkins David V 430 E. 29TH STREET 14TH FLOOR NEW YORK NY 10016 0 1 0 0 EVP, Chief Financial Officer Common Stock, $0.10 par value 2022-09-13 4 S 0 30000 71.35 D 100460 D Common Stock, $0.10 par value 2022-09-13 4 M 0 2063 48.49 A 102523 D Common Stock, $0.10 par value 2022-09-13 4 M 0 121214 48.49 A 223737 D Common Stock, $0.10 par value 2022-09-13 4 S 0 103951 71.29 D 119786 D Common Stock, $0.10 par value 204.15 I BMS Savings and Investment Program Option (right to buy) 48.49 2022-09-13 4 M 0 2063 0 D 2028-08-01 Common Stock, $0.10 par value 2063.0 0 D Option (right to buy) 48.49 2022-09-13 4 M 0 121214 0 D 2028-08-01 Common Stock, $0.10 par value 121214.0 0 D The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.350 to $71.380, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Shares acquired from options exercised in a net exercise and hold transaction with broker. 103,951 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.240 to $71.405, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Based on a plan statement as of the end of the most recent fiscal quarter. All of the shares are currently exercisable. /s/ Lisa A. Atkins, attorney-in-fact for David V. Elkins 2022-09-15